ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

MGTX MeiraGTx Holdings PLC

5,065
0,065 (1,30%)
06 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
MeiraGTx Holdings PLC MGTX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,065 1,30% 5,065 23:59:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
5,06 4,95 5,13 5,065 5,00
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
24/4/202422:30GLOBEMeiraGTx to Participate in Upcoming Investor Conferences
18/4/202422:30GLOBEMeiraGTx Announces Oral Presentation at the 2024 American..
14/3/202413:30GLOBEMeiraGTx Reports Fourth Quarter and Full Year 2023 Financial..
05/3/202400:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202414:10EDGAR2Form 8-K - Current report
13/2/202414:00GLOBEMeiraGTx Announces $50 Million Milestone from Janssen..
09/2/202416:10EDGAR2Form SCHEDULE 13G - Statement of acquisition of beneficial..
18/1/202401:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202401:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202401:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202401:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202423:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202423:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202423:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202423:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202314:30EDGAR2Form S-3 - Registration statement under Securities Act of..
21/12/202313:10EDGAR2Form 8-K - Current report
21/12/202313:00GLOBEMeiraGTx Announces Asset Purchase Agreement Involving its..
21/11/202322:30GLOBEMeiraGTx to Participate in Upcoming Investor Conferences
14/11/202314:00GLOBEMeiraGTx Announces Third Quarter 2023 Financial and..
30/10/202313:14DJNMeiraGTx Gets $30 Million Investment From Sanofi
30/10/202312:37EDGAR2Form 8-K - Current report
30/10/202312:30GLOBEMeiraGTx Announces $30 Million Strategic Investment from..
24/10/202314:30GLOBEMeiraGTx Announces an Oral Presentation and Eight Posters at..
10/8/202314:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202314:13EDGAR2Form 8-K - Current report
10/8/202314:00GLOBEMeiraGTx Reports Second Quarter 2023 Financial and..
03/8/202323:27EDGAR2Form S-3 - Registration statement under Securities Act of..
03/8/202323:22EDGAR2Form S-3 - Registration statement under Securities Act of..
01/8/202315:10GLOBEMeiraGTx Announces Poster Presentation at the 2023 American..
19/7/202314:30GLOBEMeiraGTx Announces its Wholly-Owned Gene Therapy..
27/6/202313:30GLOBEMeiraGTx Announces Positive Clinical Data from the AQUAx..
22/6/202322:01GLOBEMeiraGTx to Present 12-month Data from All Cohorts of the..
16/5/202315:00GLOBEMeiraGTx Announces the Presentation of Nine Posters at the..
11/5/202314:00GLOBEMeiraGTx Reports First Quarter 2023 Financial and..

Dernières Valeurs Consultées

Delayed Upgrade Clock